68,250€
Echtzeit-Aktienkurs Dr. Reddys Labaratories (ADRs)
Bid:
Ask:
Echtzeit-Chart der Dr. Reddys Labaratories (ADRs) Aktie
Börsenkurse Dr. Reddys Labaratories (ADRs)
| gettex | - | - | - | - | 68,500€ | -0,36% |
| Börse Stuttgart | - | - | - | - | 68,250€ | 1,11% |
| Echtzeit Euro | - | - | - | - | 68,250€ | -3,87% |
| Echtzeit USD | - | - | - | - | 74,452$ | 0,25% |
| Börse Frankfurt | - | - | - | - | 68,250€ | 0,37% |
| Lang & Schwarz | - | - | - | - | 68,250€ | 0,00% |
| New York | - | - | - | - | 74,260$ | -0,01% |
Fundamentaldaten der Dr. Reddys Labaratories (ADRs) Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2023 [USD] | 3,06 Mrd. | 746,55 Mio. | 560,77 Mio. | 0,68 | 0,60% | 100,96 | 18,57 |
| 2022 [USD] | 2,88 Mrd. | 424,04 Mio. | 316,31 Mio. | 0,38 | 0,46% | 179,13 | 19,68 |
| 2021 [USD] | 2,56 Mrd. | 349,34 Mio. | 232,21 Mio. | 0,28 | 0,41% | 243,75 | 22,13 |
| 2020 [USD] | 2,46 Mrd. | 246,40 Mio. | 274,98 Mio. | 0,33 | 0,41% | 205,57 | 22,97 |
| 2019 [USD] | 2,20 Mrd. | 314,61 Mio. | 268,72 Mio. | 0,32 | 0,38% | 210,65 | 25,73 |
| 2018 [USD] | 2,20 Mrd. | 217,12 Mio. | 152,11 Mio. | 0,18 | 0,40% | 372,95 | 25,70 |
| 2017 [USD] | 2,10 Mrd. | 213,31 Mio. | 179,53 Mio. | 0,22 | 0,43% | 315,97 | 26,94 |
| 2016 [USD] | 2,36 Mrd. | 411,04 Mio. | 305,68 Mio. | 0,36 | 0,41% | 190,64 | 24,64 |
| 2015 [USD] | 2,42 Mrd. | 457,42 Mio. | 362,74 Mio. | 0,43 | 0,43% | 160,59 | 23,99 |
| 2014 [USD] | 2,19 Mrd. | 437,37 Mio. | 356,01 Mio. | 0,42 | 0,40% | 163,67 | 26,54 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Dr. Reddys Labaratories (ADRs) Aktie
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.